Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics.
Companies covered
Abbott, Alfred E. Mann Foundation for Science Research, Animas Corporation, Baxter, Bayer, Cardiac Pacemakers Inc., Cercacor Laboratories, Dexcom, E. Heller & Company, East West Bank, Eyesense AG, GLT Acquisition Corp., Glumetrics Inc., Hudson Bay Master Fund, Isense Corporation, Legacy Good Samaritan Hospital and Medical Center, Lifescan Inc, Markwell Medical Institute, Medisense, Medtronic, Midcap Funding, National Institutes of Health, Oxygen Biotherapeutics, Panasonic, Roche Diagnostics, Sensors for Medicine and Science, Siemens, Silver James H, Therasense, University of New Mexico, Vivomedical Inc., Xoetronics LLC
List of Topics
- Overview of the blood glucose meters, including invasive and non-invasive types
- Major technology fields and sectors identified using the data mining technique; also included are top 30 assignees and their R&D strength ranking
- A brief outlook for the sales volume and value of the worldwide blood glucose meter market from 2015 to 2019
- Worldwide blood glucose meter market share by sector, and by field type
- Analysis of 30 blood glucose meter assignees’ deployment in 28 corresponding technology fields and also included is matrix analysis of 10 most important blood glucose meter patents